Occupational cancer risk surveillance in HIV-infected individuals exposed to chemicals: Role of p53 molecular marker
====================================================================================================================

* Donald C. Udah
* Adeleye S. Bakarey
* Gloria O. Anetor
* Maxwell Omabe
* Victory F. Edem
* Olusegun G. Ademowo
* John I. Anetor

## Abstract

The growing exposure to occupational chemicals and HIV infection are both major global health issues. However, there is little data on the carcinogenic risk profile of HIV-infected individuals who have been occupationally exposed to chemical mixtures. This study therefore investigated the levels of cancer risk biomarkers in HIV-infected individuals exposed to occupational chemicals, exploring the relationship between apoptotic regulatory markers and DNA oxidative response markers as a measure of cancer risk.

Apparently healthy adults (mean age 38.35±0.72years) were divided into four groups according to their HIV status and occupational chemical exposure: 62 HIV positive exposed (HPE), 66 HIV positive unexposed (HPU), 60 HIV negative exposed (HNE), and 60 HIV negative unexposed (HNU). Serum p53, bcl2, 8-hydroxydeoxyguanosine (8-OHdG), superoxide dismutase (SOD), and malondialdehyde (MDA) were estimated by standard methods. Blood samples were analysed for CD4 cell count by flow cytometry.

Serum p53 and bcl2 levels in HPE (0.91±0.11ng/ml and 122.37±15.77ng/ml) were significantly lower than HNU (1.49±0.15ng/ml and 225.52±33.67ng/ml) (p < 0.05), respectively. Wildtype p53 and bcl2 were positively and significantly correlated with 8-OHdG (r=0.35, p<0.001; r=0.36, p<0.001) and SOD (r=0.38, p<0.001; r=0.39, p<0.001). After controlling for gender, age, BMI, and cigarette smoking, both HIV status and SOD activity were significantly associated with wildtype p53 and bcl2 (p < 0.05). Malondialdehyde was significantly higher in the HPE (0.72 ± 0.01 mg/ml) than in the HNE (0.68 ± 0.01 mg/ml) and HNU (0.67 ± 0.01 mg/ml) groups (p < 0.05). Additionally, the HPE group (578.87±33.64 cells/µL) exhibited significantly lower CD4 counts than the HNE (785.35±36.8 cells/µL) and HNU (862.15±43.29 cells/µL) groups. Individuals infected with HIV and occupationally exposed to chemical substances exhibit compromised immunity, elevated oxidative stress, and depressed p53 (loss of tumour suppressive capacity) and bcl2; a convergence promoting the carcinogenic pathway and elevated cancer risk. These findings provide a mechanistic basis of cancer risk and scientific justification for preventive strategies against carcinogenesis in individuals who are HIV-infected.

Keywords
*   Cancer risk
*   HIV
*   Occupational exposure
*   Oxidative stress
*   p53

## Introduction

Epidemiological studies have demonstrated that patients with compromised immune systems, such as those seen with HIV infections, have a higher cancer incidence rate [1–3]. In addition, patients with AIDS-defining cancers had a poor prognosis prior to the introduction of Highly Active Antiretroviral Therapy (HAART), with a median survival of 5 to 6 months [4]. The increased availability of HAART has largely contributed to the reduction in the risk of AIDS-defining cancers, allowing HIV-infected individuals to live longer [5]. This has resulted to reduced incidence of malignancies linked to AIDS and weakened immunity, such as Kaposi sarcoma and non-Hodgkin’s lymphoma [6]. However, the occurrence of non-AIDS defining malignancies is increasing among people infected with HIV [7].

Although the mechanisms underlying the increased risk of cancer among HIV-infected individuals remain poorly understood, it may be associated with non-HIV factors such as occupational exposure to toxic metals. Thus, HIV infection and occupational exposure to hazardous chemicals are two risk factors that may be associated with the disruption of immunological and/or non-immune surveillance systems against cancer, especially the p53 dependent metabolic cascade. The tumour suppressor p53 and the anti-apoptotic protein bcl2 were two of the first cancer genes identified, and their interaction is critical for cancer biology [8].

Many people, including those living with HIV, work in a variety of occupations. Some of these jobs are well-known to expose workers to toxic metals like lead, mercury, chromium, and cadmium, volatile organic compounds (VOCs) like benzene particularly from sources like motor-vehicle exhaust and gasoline-vapor emissions, and skin-irritating substances including oils, greases, solvents, and detergent [9–12]. Exposure to chemical mixtures, including toxic metals, is a common risk factor for cancer, especially among certain occupational groups, because various substances prevalent in industrial and agricultural environments have been identified as carcinogenic [13–17]. These chemicals can cause DNA damage, resulting in mutations and abnormal cellular behaviour. Additionally, genetic and epigenetic alterations are known to predispose a cell clone to malignancy [18]. Multiple defence mechanisms, both immunological and non-immune surveillance system, may be employed to ward off this threat [19]. The best-known form of genetic surveillance against cancer acts through the p53-dependent pathway, with the p53 tumour suppressor gene dubbed the “Guardian of the Genome” [20]. It prevents genomic instability and suppresses tumourigenesis through regulation of diverse cellular processes including cell proliferation, DNA repair, and cell death [21].

The wildtype p53 protein binds to DNA, specifically the promoter region of p21, which is a cyclin-dependent kinase inhibitor, halting the cell cycle in the G1 phase. [22]. This cell cycle arrest allows time for cells to repair DNA damage caused by cytotoxic stressors [23]. According to Leroy *et al.* [24], more than 50% of all human tumours carry p53 mutations. These mutations impair the DNA-binding capacity of the p53 protein. Consequently, cells with damaged DNA but with maintained mitotic capacity go on dividing and increasing the risk of cancer. However, there is a paucity of studies that evaluate the p53 protein in HIV patients who are occupationally exposed to chemical mixtures. The present study aimed to evaluate whether levels of apoptotic regulatory markers p53 and bcl2 are associated with HIV infection, occupational exposure, oxidative damage, and antioxidant protection.

## Materials and Methods

### Study population

This was a cross-sectional study conducted in Nigeria involving 128 HIV positive and 120 HIV negative consenting adults, with a mean age of 38.35 ± 0.72 years. Apparently healthy HIV-positive and HIV-negative adults were recruited from both the community and a health facility between April 2017 and October 2017. Individuals who tested HIV negative in the community and those who visited the HIV Testing and Counselling units at the health facility for a voluntary HIV testing service and tested negative were matched for age, sex, and similarity in environmental as well as occupational characteristics with HIV positive cases, all recruited into the study.

A structured questionnaire was administered to elicit relevant information, including occupational exposure data. Thus, based on HIV status and occupational chemical exposure, the study population (N = 248) was divided into 4 groups: HIV positive exposed (HPE; n = 62), HIV positive unexposed (HPU; n = 66), HIV negative exposed (HNE; n = 60), and HIV negative unexposed (HNU; n = 60). The study specifically examined two distinct groups: individuals who were occupationally exposed to chemicals and an unexposed category. The occupationally exposed cohort, consistent with previous studies, had worked in professions associated with toxic metals and hazardous chemicals. These occupations included Cement factory worker [25,26], Electrician [27,28], Bars & Night clubs worker [29,30], Mechanic [9,31], Painter & Printing press worker [9,10], Weed sprayer & Pesticides worker [11,32,33], Welder [12], and Petrol Station Dispenser [34]. Furthermore, the unexposed category includes those who work in vocations that are considered low risk for toxic metal exposure, such as teachers, students, and administrative personnel in both the commercial and public sectors (data entry clerks, customer service clerks, receptionists).

The exclusion criteria for participation in the project were any history of hereditary immune deficiency, primary immune deficiency, autoimmune disease, or immunosuppressive drug use; previous cancer diagnosis; supplement use at the time of the study or within the month preceding it; prospective participants’ refusal to consent or inability to give consent to participate in this study; age <18 years. Participants were consecutively identified and recruited into the study. The HIV status of participants in this study was confirmed using the national HIV testing algorithm [35].

### Ethics statement

The study was approved by the Ethics Committee of the University of Ibadan/University College Hospital (UI/EC/16/0226) after a review process. Additionally, a written formal informed consent was obtained from all the participants selected.

### Anthropometric measurements

Body weight (kg) was measured using an electronic scale with an accuracy of 0.1 kg, and height was measured using a stadiometer with an accuracy of 0.1 cm. Each participant’s body mass index (BMI) was calculated as weight in kilograms divided by the square of the height in meters (kg/m2).

### Sample collection

Blood samples were aseptically obtained from each participant using disposable, pyrogen-free, vacutainer needles. Whole blood (5ml) was collected into serum separator tubes (SST) and 2mls into k3-EDTA vacutainers. Samples collected into SST were allowed to clot in an upright position for at least 30 minutes but not longer than 1 hour before centrifugation at 2200-2500-RPM for 15 minutes. The serum was aliquoted into cryogenic vials while other samples not immediately required were stored at −86°C until ready for analysis.

### Quantification of CD4+ lymphocytes

The identification and the enumeration of CD4+ T lymphocytes were determined using the Becton Dickinson (BD) FASCount system (Becton, Dickinson and Company, California, USA); a flow cytometry method that uses a specific monoclonal antibody and fluorescence-activated cell-sorter (FACS) analysis [36]. Samples were analyzed within 6 hours of collection. The Centers for Disease Control and Prevention (CDC) classification system of HIV-infected individuals were used to further categorize the study population into three groups: CD4 counts (a) ≥ 500 cells/µL; (b) 200-499 cells/µL and (c) <200 cells/µL [37].

### Determination p53, bcl2, SOD and 8OHdG

The serum levels of p53, bcl2, SOD and 8OHdG were determined using the ELISA method in accordance with the manufacturer’s procedure (Melsin Medical Co., Limited, China). These kits are based on the principle of a one-step double-antibody sandwich enzyme-linked immunosorbent assay (Voller *et al.*, 1978). In this approach, standard or test sample or control specimen and monoclonal antibodies specific for the analyte of interest conjugated to Horseradish Peroxidase (HRP-Conjugate) were introduced to polystyrene microwell strips pre-coated with monoclonal antibodies specific for the analyte of interest (p53 or bcl2 or SOD or 8OHdG). Chromogen solutions were added after incubation and washing, and the reaction stopped within a pre-specified time. The ELx808 Absorbance Microplate Reader (BioTek Instruments Inc., Winooski, Vermont USA) was used to determine the optical density at 450 nm. The concentrations of analytes of interest in the samples were then extrapolated from standard curves using the optical density of each sample. Internal quality control was performed by analysing external reference samples together with the test samples. Human p53 ELISA kit (Catalogue No: EKHU-0309), Human bcl2 ELISA kit (Catalogue No: EKHU-0302), Human SOD ELISA kit (Catalogue No: EKHU-1058), and Human 8OHdG ELISA kit (Catalogue No: EKHU-1276) acquired from Melsin Medical Co., Limited, China were of the highest commercially analytical grade and had an intra-assay CV (%) < 10% and Inter-assay CV (%) < 15%.

### Measurement of serum MDA levels

The Malondialdehyde (MDA) colorimetric assay previously described by Buege & Aust [38] was used. In this method, the free MDA present in the sample which was a product of lipid peroxidation, reacted with Thiobarbituric Acid (TBA) to form an MDA-TBA adduct. The absorbance of the supernatant was measured on a spectrophotometer at λ = 532 nm. The MDA concentration was calculated using the regression equation of the standard MDA (standard) solution curve.

### Statistical Analysis

Statistical Package for Social Scientists (SPSS Inc., USA) version 25.0 software was used for statistical analyses, including descriptive statistics. Continuous data were presented as mean ± standard error of mean (SEM), whereas categorical data were expressed as a frequency and percentage. The Kolmogorov Smirnov test was used to determine the normality of the variables. Parametric variables were compared using one-way analysis of variance (ANOVA), while chi-square or Fisher’s exact test was used for categorical variables. The Pearson correlation test was used to examine the relationships between measured parameters. Multiple linear regression analysis was used to determine independent predictors of the regulators of apoptosis and cell cycle (p53 and bcl2 proteins) in the entire study population. All p values less than 0.05 were deemed statistically significant.

## Results

### Demographic Characteristics

The demographic characteristics of study participants are presented in Fig 1 and Table 1. The proportions of HIV-positive and HIV-negative participants were comparable when divided into jobs that predispose workers to chemical exposure (Fig 1A) and those that do not (Fig 1B). Age, gender, place of residence, current employment status, and duration of occupation were comparable between HIV positive and HIV negative individuals in the occupationally exposed and unexposed groups (Table 1). The occupationally exposed group in this study had worked across different occupations linked to toxic metals and hazardous chemicals. While BMI was comparable between HIV positive and HIV negative individuals in the occupationally exposed group, HIV positive individuals had a significantly higher BMI than HIV negative individuals in the occupationally exposed group. The participants’ ages ranged from 18–65 years, with a mean ± SE of 38.35 ± 0.72, and they were found to have worked for an average of 10.57 ± 0.61 years. The mean duration of HIV exposure in the HIV positive group was 42.67 ± 2.45 months.

![Fig 1.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2024/01/04/2024.01.02.24300733/F1.medium.gif)

[Fig 1.](http://medrxiv.org/content/early/2024/01/04/2024.01.02.24300733/F1)

Fig 1. Comparable HIV status in study group: (A) Chemical-exposed job category and (B) Unexposed job category
A. HPE (HIV positive exposed) vs HNE (HIV negative exposed)

B. HPU (HIV positive unexposed) vs HNU (HIV negative unexposed).

χ2 = Chisquare

View this table:
[Table 1.](http://medrxiv.org/content/early/2024/01/04/2024.01.02.24300733/T1)

Table 1. Comparison of demographic characteristics of HIV-positive and HIV-negative participants within occupational categories

### Levels of p53 and other biomarkers

The levels of apoptotic regulatory biomarkers wild-type p53 and bcl2, genotoxic biomarkers 8OHdG and MDA, as well as the antioxidant enzyme SOD and the immunological marker CD4, are presented in Fig 2. The molecular markers p53 and bcl2 decreased in the HPE group compared to the HPU, HNE, and HNU groups, respectively. While the HPE group had significantly lower p53 and bcl2 levels than the HNU group (p = 0.01 and p = 0.03 respectively), comparisons between the HPE group and the other two groups [HPU (p = 0.99 and p = 0.84 respectively) and HNE (p = 0.18 and p = 0.14 respectively)] were not significant. In contrast, the HPE group had higher 8OHdG levels than the HPU and HNE groups, although the difference was not statistically significant (p = 0.19 and p = 0.44 respectively). Additionally, SOD activity decreased in the HPE group relative to the HPU, HNE, and HNU groups, but the difference was not significant (p > 0.05). The MDA levels were significantly higher in the HPE group than in the HNE or HNU groups, respectively (p = 0.04 and p = 0.01 respectively). Additionally, the HPE group had higher MDA levels than the HPU group, but the difference was not significant (p > 0.05). Moreover, p53 and bcl2 levels were positively and significantly correlated with 8OHdG (r=0.35, p<0.001; r=0.36, p<0.001), SOD (r=0.38, p<0.001; r=0.39, p<0.001) whereas p53 and bcl2 levels were negatively but not significantly correlated with MDA (r=-0.03, p=0.67; r=-0.05, p=0.43) (Table 2).

![Fig 2.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2024/01/04/2024.01.02.24300733/F2.medium.gif)

[Fig 2.](http://medrxiv.org/content/early/2024/01/04/2024.01.02.24300733/F2)

Fig 2. Comparison of the levels of p53 and other markers across study group
*Overall p-value across the study group (ANOVA results)

bcl2 = β-cell lymphoma; 8-OHdG = 8-Hydroxydeoxyguanosine; SOD = Superoxide Dismutase; MDA = Malondialdehyde

Pairwise comparison (Post hoc analysis): Bars with no superscript letter in common differ significantly (p < 0.05). The error bars show the standard error of the mean; values are mean ± Standard Error.

Study groups: HIV positive exposed (HPE; n = 62), HIV positive unexposed (HPU; n = 66), HIV negative exposed (HNE; n = 60), and HIV negative unexposed (HNU; n = 60).

View this table:
[Table 2.](http://medrxiv.org/content/early/2024/01/04/2024.01.02.24300733/T2)

Table 2. Correlations between the evaluated biomarkers in the study population

### CD4 cell count - an indicator of immunological function

The immunological condition of the occupationally exposed and unexposed research participants is summarised in Fig 2 and Table 3 using the Centers for Disease Control and Prevention (CDC) CD4 count classification criteria of 500 cells/L; 200-499 cells/L; and 200 cells/L. In the occupationally exposed group, a significantly smaller proportion of HIV positive participants (54.8%) had CD4 cell counts ≥500cells/µL compared with 85% of HIV negative participants. Similarly, in the occupationally unexposed group, a significantly smaller proportion of HIV positive participants (50%) had CD4 cell counts ≥500cells/µL compared with 93.3% of HIV negative participants.

View this table:
[Table 3.](http://medrxiv.org/content/early/2024/01/04/2024.01.02.24300733/T3)

Table 3. Immunological Status of Study Groups

A bar chart indicating the possible association between two categorical variables, occupational chemical exposure and CD4 cell count stratified by HIV status, is depicted in Fig 2. There was no association between occupational exposure and CD4 count categories in the HIV positive study participants (χ2 (2) = 4.43, p = 0.11) and in the HIV negative individuals (χ2 (2) = 2.16, p = 0.14). However, the occupationally exposed HIV positive group (578.87 ± 33.64 cells/µL) and the HIV positive unexposed group (553.95 ± 36.86 cells/µL) had significantly lower CD4 counts than the HIV negative exposed (785.35 ± 36.8 cells/µL) and HIV negative unexposed (862.15 ± 43.29 cells/µL) groups (Fig 2). CD4 cell count was negatively and significantly correlated with MDA (r=-0.14, p=0.03) (Table 2).

### Multiple linear regression for indicators of genotoxicity and apoptosis regulation

To examine the relationship between indicators of genotoxicity and apoptosis regulation using multiple linear regression, occupational chemical exposure, HIV status, CD4, SOD, 8OHdG, and MDA were used as predictor variables, while apoptosis regulation markers, p53 and bcl2 were used as dependent variables. After adjusting for sex, age, BMI, and cigarette smoking, both HIV status and SOD activity were significantly associated with wildtype p53 and bcl2 (p < 0.05) (Table 4).

View this table:
[Table 4.](http://medrxiv.org/content/early/2024/01/04/2024.01.02.24300733/T4)

Table 4. Effect of occupational exposure, HIV status and other biomarkers on p53 and bcl2

## DISCUSSION

The co-occurrence of HIV infection and occupational exposure to hazardous chemicals poses a major concern in public health, as both factors may facilitate the concurrent degradation of both immunological and non-immune surveillance mechanisms against cancer. This study investigated the complex association between apoptotic regulatory markers and DNA oxidative response markers in the context of cancer susceptibility among individuals infected with HIV, who were also exposed to a cocktail of hazardous substances, including metals. The findings of this study indicate that p53 and bcl2 levels, which control apoptosis, were associated with HIV infection, oxidative damage, and a tendency for antioxidant depletion. Additionally, the decrease in wildtype p53 and bcl2 levels, as well as the increase in malondialdehyde levels, among HIV-positive individuals who had occupational exposure to chemical mixtures provides insight into the potential role of oxidative stress in viral and chemical carcinogenesis.

Individuals who were HIV-positive and had been exposed to chemical mixtures at work demonstrated notably reduced levels of p53 and bcl2 in comparison to HIV-negative persons who had not been exposed. This observation implies a plausible association between the co-occurrence of HIV infection and exposure to occupational chemicals, and a disruption in the apoptotic pathways. The proteins p53 and bcl2 are crucial in maintaining the equilibrium between cell survival and cell death [39]. Hence, the observed decrease in p53 and bcl2 levels could indicate an imbalance between cell proliferation and apoptosis in individuals infected by HIV and exposed to hazardous chemical agents, suggestive of a potential predisposition to malignancy. In a study that shares some similarities, Gruevska *et al.* [40] found that HIV patients had significantly lower levels of the tumour suppressor gene p53 than uninfected matched individuals, and that this decreased expression of p53 was also observed at the protein level.

Malondialdehyde functions as a reliable marker for assessing lipid peroxidation and oxidative damage. In this study, occupationally exposed HIV positive individuals had increased MDA levels, indicating that individuals infected with HIV and exposed to occupational chemicals experience elevated levels of oxidative stress. This finding is consistent with the literature suggesting that exposure to certain chemicals in the workplace, such as toxic metals, may cause oxidative stress, leading to further damage to cellular constituents, including DNA [41,42]. Indeed, the presence of HIV infection may create an enabling environment favourable for cancer development, owing to immune suppression as well as processes such as DNA mutations and defective DNA repair, which can be attributed to mitochondrial dysfunction and elevated oxidative stress [43].

Oxidative stress in occupationally exposed HIV-infected individuals, may contribute to the impairment of p53 function, potentially leading to the initiation or progression of carcinogenesis. Although p53 is generally activated in response to DNA damage, chronic exposure to occupational carcinogens may result in prolonged activation and ultimately depletion of p53. Therefore, the decreased wildtype p53 in response to chronic occupational chemical exposure and HIV infection observed in this study may compromise the critical role of p53 in preserving DNA integrity and preventing cancer. This agrees with studies demonstrating that people living with HIV or exposed to chemical carcinogens showed increased genomic instability [16,44]. Oxidative stress plays a critical role in chemical and viral carcinogenesis [45,46].

Multiple factors could potentially influence the susceptibility of cells to cancer. The observed association between HIV status, 8OHdG and SOD, with levels of wildtype p53 and bcl2 suggest that these indicators are influenced not only by individual exposures but also by the combined factors altering cellular responses to oxidative stress and apoptosis. The complex relationship between these factors highlights the diverse and intricate mechanisms that contribute to the risk of cancer in people living with HIV but also exposed to chemical toxins. This observation is consistent with previous studies that proposed a relationship between HIV infection and oxidative stress, which can result in changes to cellular mechanisms, such as apoptotic pathways [43,47]. Darbinian *et al.* [48] demonstrated the initiation of apoptotic responses following elevated mtDNA damage in cells treated with HIV-1 proteins or infected with HIV-1. Conversely, the accumulation of damaged DNA can result from abnormal or failure of apoptosis which may lead to cancer [49].

A decreased CD4 cell count was observed in HIV-infected individuals regardless of occupational chemical exposure. This aligns with the prevailing consensus that HIV infection impairs the immune system by preferentially destroying CD4-positive T cells. Indeed, the altered immunological profiles of the HIV-positive study population are consistent with previous research on the detrimental effect of HIV infection on immune system functionality [50,51]. Moreover, the observation of a negative correlation between CD4 count and MDA concentrations provides further evidence for the probable influence of both HIV infection and chemical exposures on cellular pathways associated with oxidative stress and apoptosis. Our findings suggest that impaired immune surveillance indicated by low CD4 cell count may impede the body’s capacity to identify and eradicate malignant or pre-malignant cells, therefore play a role in increased cancer risk among HIV-infected workers. Furthermore, these findings are consistent with evidence indicating that oxidative stress plays a pivotal role in the interconnection between viral infections, hazardous exposures, and the development of cancer [52–54]. This may potentially interact with chemical exposures, leading to an increased vulnerability to cancer. Kang *et al.* [55] demonstrated that an intact CD4(+) T-cell-mediated adaptive immune response is important for tumour immune surveillance.

The present study highlights the complex relationships among apoptotic regulatory indicators, DNA oxidative response markers, and the risk of cancer in a distinct population of HIV-infected individuals who have been occupationally exposed to hazardous chemicals. Notably, the current study underscored the influence of both HIV infection and chemical exposures on cellular pathways associated with oxidative stress and apoptosis. The majority of prior studies focused on the influence of HIV infection or occupational exposure on oxidative stress indicators in isolation [54,56]. However, it is imperative to acknowledge the study’s limitations. The cross-sectional design makes it difficult to establish causal relationships between occupational chemical exposure, HIV infection, and changes in levels of cancer risk biomarkers studied. Secondly, the study did not investigate specific cancer types or long-term cancer outcomes, which could have provided valuable insight into the clinical implications of these findings. Longitudinal studies are advocated to provide more robust evidence.

## Conclusion

Immune deficiency, antioxidant deficits, oxidative stress, and dysregulation of apoptosis contribute to increased genomic instability and elevated cancer risk in HIV infected individuals occupationally exposed to chemical mixtures. In addition, our findings suggest that optimal levels of the enzymatic antioxidant SOD may be essential for p53 to play its protective role in maintaining genomic stability. These findings highlight the need of designing and implementing preventive interventions to reduce the risk of viral and chemical carcinogenesis among the vulnerable population of HIV-infected individuals exposed to occupational chemical hazards.

## Data Availability

Our research data is available to all interested parties on the Open Science Framework (OSF) repository, which allows for unrestricted data use. The link to access the dataset is provided below: [https://osf.io/vj6wp/?view_only=ff2c2c4cf7024a42a0452531ad6902c1](https://osf.io/vj6wp/?view_only=ff2c2c4cf7024a42a0452531ad6902c1)

[https://osf.io/vj6wp/?view\_only=ff2c2c4cf7024a42a0452531ad6902c1](https://osf.io/vj6wp/?view_only=ff2c2c4cf7024a42a0452531ad6902c1) 

## Author Contributions

Conceptualization: Donald C. Udah, Adeleye S. Bakarey, Olusegun G. Ademowo, John I. Anetor

Data curation: Donald C. Udah, Adeleye S. Bakarey, Maxwell Omabe, Victory F. Edem

Formal analysis: Donald C. Udah, Gloria O. Anetor, Olusegun G. Ademowo, John I. Anetor

Funding acquisition: Donald C. Udah, John I. Anetor

Investigation: Donald C. Udah, Adeleye S. Bakarey, Gloria O. Anetor, Victory F. Edem, Olusegun G. Ademowo, John I. Anetor

Methodology: Donald C. Udah, Adeleye S. Bakarey, Gloria O. Anetor, Maxwell Omabe, Victory F. Edem

Supervision: Olusegun G. Ademowo, John I. Anetor

Visualization: Donald C. Udah, Maxwell Omabe

Writing – original draft: Donald C. Udah

Writing – review & editing: Donald C. Udah, Adeleye S. Bakarey, Gloria O. Anetor, Maxwell Omabe, Victory F. Edem, Olusegun G. Ademowo, John I. Anetor

## Acknowledgements

The authors extend their gratitude to the study’s community outreach team, led by Mr. Saviour Nkanu, for their support in participant recruitment and to all participants involved in this study.

*   Received January 2, 2024.
*   Revision received January 2, 2024.
*   Accepted January 4, 2024.


*   © 2024, Posted by Cold Spring Harbor Laboratory

This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/)

## References

1.  1.Engels EA, Pfeiffer RM, Fraumeni JFJ, Kasiske BL, Israni AK, Snyder JJ, et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA. 2011;306: 1891–1901. doi:10.1001/jama.2011.1592
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1001/jama.2011.1592&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=22045767&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F01%2F04%2F2024.01.02.24300733.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000296376200023&link_type=ISI) 

2.  2.Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet (London, England). 2007;370: 59–67. doi:10.1016/S0140-6736(07)61050-2
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/S0140-6736(07)61050-2&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=17617273&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F01%2F04%2F2024.01.02.24300733.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000247862300031&link_type=ISI) 

3.  3.Schwartz RS. Immunodeficiency, immunosuppression, and susceptibility to neoplasms. J Natl Cancer Inst Monogr. 2001; 5–9. doi:10.1093/oxfordjournals.jncimonographs.a024257
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1093/oxfordjournals.jncimonographs.a003460&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=11773285&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F01%2F04%2F2024.01.02.24300733.atom) 

4.  4.Castelli R, Schiavon R, Preti C, Ferraris L. Hiv-Related Lymphoprolipherative Diseases In The Era Of Combination Antiretroviral Therapy. Cardiovascular & hematological disorders drug targets. United Arab Emirates; 2020. doi:10.2174/1871529X20666200415121009
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.2174/1871529X20666200415121009&link_type=DOI) 

5.  5.Odutola M, Jedy-Agba EE, Dareng EO, Oga EA, Igbinoba F, Otu T, et al. Burden of Cancers Attributable to Infectious Agents in Nigeria: 2012-2014. Front Oncol. 2016;6: 216. doi:10.3389/fonc.2016.00216
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3389/fonc.2016.00216&link_type=DOI) 

6.  6.Zucchetto A, Virdone S, Taborelli M, Grande E, Camoni L, Pappagallo M, et al. Non-AIDS-Defining Cancer Mortality: Emerging Patterns in the Late HAART Era. J Acquir Immune Defic Syndr. 2016;73: 190–196. doi:10.1097/QAI.0000000000001033
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1097/QAI.0000000000001033&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F01%2F04%2F2024.01.02.24300733.atom) 

7.  7.Franzetti M, Ricci E, Bonfanti P. The Pattern of Non-AIDS-defining Cancers in the HIV Population: Epidemiology, Risk Factors and Prognosis. A Review. Curr HIV Res. 2019;17: 1–12. doi:10.2174/1570162X17666190327153038
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.2174/1570162X17666190327153038&link_type=DOI) 

8.  8.Hemann MT, Lowe SW. The p53-bcl-2 connection. Cell Death Differ. 2006;13: 1256.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1038/sj.cdd.4401962&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=16710363&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F01%2F04%2F2024.01.02.24300733.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000239084900004&link_type=ISI) 

9.  9.Omotosho IO. Oxidative stress indices as markers of lead and cadmium exposure toxicity in auto technicians in Ibadan, Nigeria. Oxid Med Cell Longev. 2019;2019.
    
    

10. 10.Guth K, Bourgeois M, Johnson G, Harbison R. Assessment of lead exposure controls on bridge painting projects using worker blood lead levels. Regul Toxicol Pharmacol. 2020;115: 104698. doi:10.1016/j.yrtph.2020.104698
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.yrtph.2020.104698&link_type=DOI) 

11. 11.Peters CE, Parent M-É, Harris SA, Bogaert L, Latifovic L, Kachuri L, et al. Occupational Exposure to Diesel and Gasoline Engine Exhausts and the Risk of Kidney Cancer in Canadian Men. Ann Work Expo Heal. 2018;62: 978–989. doi:10.1093/annweh/wxy059
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1093/annweh/wxy059&link_type=DOI) 

12. 12.Torén K, Blanc PD, Naidoo RN, Murgia N, Qvarfordt I, Aspevall O, et al. Occupational exposure to dust and to fumes, work as a welder and invasive pneumococcal disease risk. Occup Environ Med. 2020;77: 57–63. doi:10.1136/oemed-2019-106175
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NToib2VtZWQiO3M6NToicmVzaWQiO3M6NzoiNzcvMi81NyI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDI0LzAxLzA0LzIwMjQuMDEuMDIuMjQzMDA3MzMuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 

13. 13.Poirier MC. Linking DNA adduct formation and human cancer risk in chemical carcinogenesis. Environ Mol Mutagen. 2016;57: 499–507. doi:10.1002/em.22030
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1002/em.22030&link_type=DOI) 

14. 14.Anetor, J.I., Udah, D., Akingbola, T. S., Anetor, G. O., Babalola, O., Igharo, O.G., Uche, Z. C., & Adeniyi FAA. Upregulation of gamma-glutamyltranspeptidase activity and uric acid level in mixed chemical exposure: Implications for mutagenic and pre-neoplastic events. Int J Biol Chem Sci. 2016;10: 2655–2666.
    
    

15. 15.International Agency for Research on Cancer (IARC). Chemical agents and related occupations. IARC Monogr Eval Carcinog risks to humans. 2012;100: 9–562.
    
    

16. 16.Kovalchuk O. Chemical carcinogens and their effect on genome and epigenome stability. Genome Stability. Elsevier; 2021. pp. 589–602.
    
    

17. 17.Barsouk A, Thandra KC, Saginala K, Rawla P, Barsouk A. Chemical Risk Factors of Primary Liver Cancer: An Update. Hepat Med. 2020;12: 179–188. doi:10.2147/HMER.S278070
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.2147/HMER.S278070&link_type=DOI) 

18. 18.Hatano Y, Ideta T, Hirata A, Hatano K, Tomita H, Okada H, et al. Virus-Driven Carcinogenesis. Cancers (Basel). 2021;13. doi:10.3390/cancers13112625
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3390/cancers13112625&link_type=DOI) 

19. 19.Klein G, Klein E. Surveillance against tumors—is it mainly immunological? Immunol Lett. 2005;100: 29–33.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.imlet.2005.06.024&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=16129497&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F01%2F04%2F2024.01.02.24300733.atom) 

20. 20.Okorokov AL, Orlova E V. Structural biology of the p53 tumour suppressor. Curr Opin Struct Biol. 2009;19: 197–202. doi:10.1016/j.sbi.2009.02.003
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.sbi.2009.02.003&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=19286366&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F01%2F04%2F2024.01.02.24300733.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000266114000012&link_type=ISI) 

21. 21.Park J-H, Zhuang J, Li J, Hwang PM. p53 as guardian of the mitochondrial genome. FEBS Lett. 2016;590: 924–934. doi:10.1002/1873-3468.12061
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1002/1873-3468.12061&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=26780878&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F01%2F04%2F2024.01.02.24300733.atom) 

22. 22.Stewart-Ornstein J, Lahav G. p53 dynamics in response to DNA damage vary across cell lines and are shaped by efficiency of DNA repair and activity of the kinase ATM. Sci Signal. 2017;10. doi:10.1126/scisignal.aah6671
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6ODoic2lndHJhbnMiO3M6NToicmVzaWQiO3M6MTU6IjEwLzQ3Ni9lYWFoNjY3MSI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDI0LzAxLzA0LzIwMjQuMDEuMDIuMjQzMDA3MzMuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 

23. 23.Pellegata NS, Antoniono RJ, Redpath JL, Stanbridge EJ. DNA damage and p53-mediated cell cycle arrest: a reevaluation. Proc Natl Acad Sci. 1996;93: 15209–15214.
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoicG5hcyI7czo1OiJyZXNpZCI7czoxMToiOTMvMjYvMTUyMDkiO3M6NDoiYXRvbSI7czo1MDoiL21lZHJ4aXYvZWFybHkvMjAyNC8wMS8wNC8yMDI0LjAxLjAyLjI0MzAwNzMzLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==) 

24. 24.Leroy B, Anderson M, Soussi T. TP53 mutations in human cancer: database reassessment and prospects for the next decade. Hum Mutat. 2014;35: 672–688. doi:10.1002/humu.22552
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1002/humu.22552&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=24665023&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F01%2F04%2F2024.01.02.24300733.atom) 

25. 25.Obaji-Ogar LT, Nsonwu-Anyanwu AC, Odum FA. Oxidative DNA Damage and Pro-inflammatory Response In Chronic Exposure To Cement Dust. Asia Pacific J Med Toxicol. 2020;9: 3–10.
    
    

26. 26.Ogunbileje JO, Sadagoparamanujam V-M, Anetor JI, Farombi EO, Akinosun OM, Okorodudu AO. Lead, mercury, cadmium, chromium, nickel, copper, zinc, calcium, iron, manganese and chromium (VI) levels in Nigeria and United States of America cement dust. Chemosphere. 2013;90: 2743–2749.
    
    

27. 27.Igharo OG, Anetor JI, Osibanjo O, Okungbowa MA, Aleoghena TO, Idomeh FA, et al. Variation in Some Haematological Parameters, Iron and Lead Levels in Workers Exposed to Electronic Waste in Benin City, South-South Nigeria. J Med Lab Sci. 2020;30: 50–58.
    
    

28. 28.Ward MS, Henderson AM, Rossi E, Raven JL. Lead poisoning in an electrician: a bad substitute for a bad habit. Med J Aust. 1997;166: 23–24. doi:10.5694/j.1326-5377.1997.tb138697.x
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.5694/j.1326-5377.1997.tb138697.x&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=9006608&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F01%2F04%2F2024.01.02.24300733.atom) 

29. 29.Wortley PM, Caraballo RS, Pederson LL, Pechacek TF. Exposure to secondhand smoke in the workplace: serum cotinine by occupation. J Occup Environ Med. 2002;44: 503–509. doi:10.1097/00043764-200206000-00010
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1097/00043764-200206000-00010&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=12085475&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F01%2F04%2F2024.01.02.24300733.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000176267200010&link_type=ISI) 

30. 30.Semple S, Maccalman L, Naji AA, Dempsey S, Hilton S, Miller BG, et al. Bar workers’ exposure to second-hand smoke: the effect of Scottish smoke-free legislation on occupational exposure. Ann Occup Hyg. 2007;51: 571–580. doi:10.1093/annhyg/mem044
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1093/annhyg/mem044&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=17846033&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F01%2F04%2F2024.01.02.24300733.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000250673400001&link_type=ISI) 

31. 31.Rabczyński M, Kuźnik E, Guziński M, Adamiec R. Critical ischemia of the fingers in an auto mechanic as a result of occupational exposure. Int J Occup Med Environ Health. 2015;28: 169–173. doi:10.2478/s13382-014-0293-5
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.2478/s13382-014-0293-5&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F01%2F04%2F2024.01.02.24300733.atom) 

32. 32.Moura LTR de, Bedor CNG, Lopez RVM, Santana VS, Rocha TMB da S da, Wünsch Filho V, et al. Occupational exposure to organophosphate pesticides and hematologic neoplasms: a systematic review. Rev Bras Epidemiol. 2020;23: e200022. doi:10.1590/1980-549720200022
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1590/1980-549720200022&link_type=DOI) 

33. 33.Buralli RJ, Ribeiro H, Iglesias V, Muñoz-Quezada MT, Leão RS, Marques RC, et al. Occupational exposure to pesticides and health symptoms among family farmers in Brazil. Rev Saude Publica. 2020;54: 133. doi:10.11606/s1518-8787.2020054002263
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.11606/s1518-8787.2020054002263&link_type=DOI) 

34. 34.Ghittori S, Ferrari M, Maestri L, Negri S, Zadra P, Gremita C, et al. [The significance of enviromental and biological monitoring in workers employed in service stations after the elimitation of tetraethyl lead from gasoline]. G Ital Med Lav Ergon. 2005;27: 137–153.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=16124521&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F01%2F04%2F2024.01.02.24300733.atom) 

35. 35.Patel HK, Ikpe S, Bronson M, Birhanu S, Abimiku A, Jahun I, et al. Performance of HIV rapid testing algorithm in Nigeria: Findings from a household-based Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS). PLOS Glob Public Heal. 2022;2: e0000466.
    
    

36. 36.Pattanapanyasat K, Sukapirom K, Kowawisatsut L, Thepthai C. New BD FACSCount CD4 reagent system for simultaneous enumeration of percent and absolute CD4 T-lymphocytes in HIV-1-infected pediatric patients. Cytometry B Clin Cytom. 2008;74 Suppl 1: S98–106. doi:10.1002/cyto.b.20415
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1002/cyto.b.20415&link_type=DOI) 

37. 37.CDC. Revised surveillance case definition for HIV infection--United States, 2014. MMWR Recomm reports Morb Mortal Wkly report Recomm reports. 2014;63: 1–10.
    
    

38. 38.Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1978;52: 302–310. doi:10.1016/s0076-6879(78)52032-6
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/S0076-6879(78)52032-6&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=672633&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F01%2F04%2F2024.01.02.24300733.atom) 

39. 39. Ayed D Ben, Khabir A, Abid M, Bayrouti MI, Gargouri A, Sellami-Boudawara T, et al. Clinicopathological and prognostic significance of p53, Ki-67, and Bcl-2 expression in Tunisian gastric adenocarcinomas. Acta Histochem. 2014;116: 1244–1250. doi:10.1016/j.acthis.2014.07.008
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.acthis.2014.07.008&link_type=DOI) 

40. 40.Gruevska A, Moragrega AB, Galindo MJ, Esplugues J V, Blas-Garcia A, Apostolova N. p53 and p53-related mediators PAI-1 and IGFBP-3 are downregulated in peripheral blood mononuclear cells of HIV-patients exposed to non-nucleoside reverse transcriptase inhibitors. Antiviral Res. 2020;178: 104784. doi:10.1016/j.antiviral.2020.104784
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.antiviral.2020.104784&link_type=DOI) 

41. 41.Fu Z, Xi S. The effects of heavy metals on human metabolism. Toxicol Mech Methods. 2020;30: 167–176. doi:10.1080/15376516.2019.1701594
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1080/15376516.2019.1701594&link_type=DOI) 

42. 42.Gueguen Y, Bontemps A, Ebrahimian TG. Adaptive responses to low doses of radiation or chemicals: their cellular and molecular mechanisms. Cell Mol Life Sci. 2018. doi:10.1007/s00018-018-2987-5
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s00018-018-2987-5&link_type=DOI) 

43. 43.Schank M, Zhao J, Moorman JP, Yao ZQ. The Impact of HIV- and ART-Induced Mitochondrial Dysfunction in Cellular Senescence and Aging. Cells. 2021;10. doi:10.3390/cells10010174
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3390/cells10010174&link_type=DOI) 

44. 44.Gutiérrez-Sevilla JE, Cárdenas-Bedoya J, Escoto-Delgadillo M, Zúñiga-González GM, Pérez-Ríos AM, Gómez-Meda BC, et al. Genomic instability in people living with HIV. Mutat Res Genet Toxicol Environ Mutagen. 2021;865: 503336. doi:10.1016/j.mrgentox.2021.503336
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.mrgentox.2021.503336&link_type=DOI) 

45. 45.Isaguliants M, Bayurova E, Avdoshina D, Kondrashova A, Chiodi F, Palefsky JM. Oncogenic Effects of HIV-1 Proteins, Mechanisms Behind. Cancers (Basel). 2021;13. doi:10.3390/cancers13020305
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3390/cancers13020305&link_type=DOI) 

46. 46.Klaunig JE, Wang Z, Pu X, Zhou S. Oxidative stress and oxidative damage in chemical carcinogenesis. Toxicol Appl Pharmacol. 2011;254: 86–99. doi:10.1016/j.taap.2009.11.028
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.taap.2009.11.028&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=21296097&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F01%2F04%2F2024.01.02.24300733.atom) 

47. 47.Lagathu C, Cossarizza A, Béréziat V, Nasi M, Capeau J, Pinti M. Basic science and pathogenesis of ageing with HIV: potential mechanisms and biomarkers. AIDS. 2017;31 Suppl 2: S105–S119. doi:10.1097/QAD.0000000000001441
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1097/QAD.0000000000001441&link_type=DOI) 

48. 48.Darbinian N, Darbinyan A, Merabova N, Selzer ME, Amini S. HIV-1 and HIV-1-Tat Induce Mitochondrial DNA Damage in Human Neurons. J HIV AIDS. 2020;6. doi:10.16966/2380-5536.176
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.16966/2380-5536.176&link_type=DOI) 

49. 49.D’arcy MS. Cell death: a review of the major forms of apoptosis, necrosis and autophagy. Cell Biol Int. 2019;43: 582–592.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1002/cbin.11137&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=30958602&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F01%2F04%2F2024.01.02.24300733.atom) 

50. 50.de Goede AL, Vulto AG, Osterhaus ADME, Gruters RA. Understanding HIV infection for the design of a therapeutic vaccine. Part I: Epidemiology and pathogenesis of HIV infection. Ann Pharm Fr. 2015;73: 87–99. doi:10.1016/j.pharma.2014.11.002
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.pharma.2014.11.002&link_type=DOI) 

51. 51.Fernández-Ruiz A, Sanjoaquín-Conde I, Letona-Carbajo S, Lambea-Sorrosal JJ, Crusells-Canales MJ. Differences in survival according to malignancy type and degree of immunodeficiency in HIV-infected patients. Med Clin (Barc). 2020;154: 295–300. doi:10.1016/j.medcli.2019.06.019
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.medcli.2019.06.019&link_type=DOI) 

52. 52.Kumar N, Kumari V, Ram C, Kumar BSB, Verma S. Impact of oral cadmium intoxication on levels of different essential trace elements and oxidative stress measures in mice: a response to dose. Environ Sci Pollut Res. 2018;25: 5401–5411.
    
    

53. 53.Adeyanju K, Bend JR, Rieder MJ, Dekaban GA. HIV-1 tat expression and sulphamethoxazole hydroxylamine mediated oxidative stress alter the disulfide proteome in Jurkat T cells. Virol J. 2018;15: 82. doi:10.1186/s12985-018-0991-x
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1186/s12985-018-0991-x&link_type=DOI) 

54. 54.Anlar HG, Bacanli M, İritaş S, Bal C, Kurt T, Tutkun E, et al. Effects of Occupational Silica Exposure on OXIDATIVE Stress and Immune System Parameters in Ceramic Workers in TURKEY. J Toxicol Environ Health A. 2017;80: 688–696. doi:10.1080/15287394.2017.1286923
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1080/15287394.2017.1286923&link_type=DOI) 

55. 55.Kang T-W, Yevsa T, Woller N, Hoenicke L, Wuestefeld T, Dauch D, et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature. 2011;479: 547–551. doi:10.1038/nature10599
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1038/nature10599&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=22080947&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F01%2F04%2F2024.01.02.24300733.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000297285600055&link_type=ISI) 

56. 56.Mebrat Y, Amogne W, Mekasha A, Gleason RLJ, Seifu D. Lipid Peroxidation and Altered Antioxidant Profiles with Pediatric HIV Infection and Antiretroviral Therapy in Addis Ababa, Ethiopia. J Trop Pediatr. 2017;63: 196–202. doi:10.1093/tropej/fmw076
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1093/tropej/fmw076&link_type=DOI)